IgA nephropathy databank: Development of a system for management of renal biopsy acquired data

American Journal of Kidney Diseases

Volumn 29, Issue 6, 1997, Pages 817-828

  Wyatt, Robert J ^a   Emancipator, Steven N ^b   Kon, Valentina ^b   Waldo, F Bryson ^b   Donadio, James ^b   Grande, Joseph P ^b   Andreoli, Sharon P ^b   Glassock, Richard J ^b  

^a LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^b NONE

Author keywords

IgA nephropathy; Prognosis; Renal biopsy

Indexed keywords

ARTICLE; DATA BASE; IMMUNOGLOBULIN A NEPHROPATHY; INFORMATION RETRIEVAL; INFORMATION SERVICE; KIDNEY BIOPSY; PATIENT INFORMATION;

EID: 0030965786     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90455-8     Document Type: Article

References (45)

1. Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH: IgA nephropathy: Presentation, clinical course and prognosis in children and adults. Am J Kidney Dis 4:192-200, 1984
2. Wyatt RJ, Kritchevsky SB, Woodford SY, Miller PM, Roy S III, Holland NH, Bishof NA: IgA nephropathy: Long-term prognosis for pediatric patients. J Pediatr 127:913-919, 1995
3. Southwest Pediatric Nephrology Study Group: A multicenter study of IgA nephropathy in children: A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 22:643-652, 1982
4. Simon P, Ramée M-P, Autuly V, Laruelle E, Charasse C, Cam G, Ang KS: Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. Kidney Int 46:1192-1198, 1994
5. Berthoux FC, Gagne C, Gagne A, Le Petit JC, Sabatier JC: HLA-Bw35 antigen and mesangial IgA glomerulonephritis: A poor prognosis marker. Proc Eur Dial Transplant Assoc 16:551-555, 1979
6. Kashiwabara H, Shishido H, Tomura S, Tuchida H, Miyajima T: Strong association between IgA nephropathy and HLA-DR4 antigen. Kidney Int 22:377-382, 1982
7. Freeman BI, Spray BJ, Heise ER: HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am J Kidney Dis 23:352-357, 1994
8. Wyatt RJ, Julian BA, Woodford SY, Wang C, Roberts J, Thompson JS, Christienson MJ, McLean RH: C4A deficiency and poor prognosis in patients with IgA nephropathy. Clin Nephrol 36:1-5, 1991
9. Wyatt RJ, Julian BA, Woodford SY, McLean RH, Thompson JS: Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy. Semin Nephrol 7:389-392, 1987
10. Wopenka U, Thysell H, Sjöholm AG, Truedsson L: C4 phenotypes in IgA nephropathy: Disease progression associated with C4A deficiency but not with C4 isotype concentrations. Clin Nephrol 45:141-145, 1996
11. Hunley TE, Julian BA, Phillips JA III, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577, 1996
12. Lee K, Rao WV, Franklin W, Schiffer MS, Aronson AJ, Spargo BH, Katz AI: IgA nephropathy: Morphologic predictors of progressive disease. Hum Pathol 12:314-322, 1982
13. Mina SN, Murphy WM: IgA nephropathy: A comparative study of the clinicopathologic features in children and adults. Am J Clin Pathol 83:669-675, 1985
14. Kobayashi Y, Tateno S, Hiki Y, Shigematsu H: IgA nephropathy: Prognostic significance of proteinuria and histologic alterations. Nephron 34:146-153, 1983
15. Alamartine E, Sabatier JC, Bertoux FC: Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: Value of quantitative scoring and approach to final prognosis. Clin Nephrol 34:45-51, 1990
16. Andreoli SP, Bergstein JM: Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248-253, 1989
17. Waldo FB, Wyatt RJ, Kelly DR, Herrera GA, Benefield MR, Kohaut EC: Treatment of IgA nephropathy in children: Efficacy of alternate-day oral prednisone. Pediatr Nephrol 7:529-532, 1993
18. Hood SA, Velosa JA, Holley KE, Donadio JV Jr: IgA-IgG nephropathy: Predictive indices of progressive disease. Clin Nephrol 16:55-62, 1981
19. Donadio JV Jr, Bergstralh EJ, Offord KP, Holley KE, Spencer DC, for the Mayo Nephrology Collaborative Group: Clinical and histopathological associations with impaired renal function in IgA nephropathy. Clin Nephrol 41:65-71, 1994
20. Austin HA, Muenz LR, Joyce KM, Antonovgeh TA, Kullick ME, Klippel JH, Decker JL, Balow JE: Prognostic factors in lupus nephritis: Contribution of renal histologic data. Am J Med 75:382-391, 1983
21. Andreoli SP, Yum NM, Bergstein JM: IgA nephropathy in children: Significance of glomerular basement membrane deposition of IgA. Am J Nephrol 6:28-33, 1986
22. Pirani CL: Renal biopsy: An historical perspective, in Silva FG, D'Agati VD, Nadasdy T (eds): Renal Biopsy Interpretation. New York, NY, Churchill Livingstone, 1996, pp 1-19
23. Heptinstall RH: The development of renal pathology. Am J Kidney Dis 16:568-573, 1990
24. Churg J, Sobin LH: Renal Disease: Classification and Atlas of Glomerular Diseases. Tokyo, Japan, Igaku-Shoin, 1982
25. Emancipator SN: Primary and secondary forms of IgA nephritis, Schönlein-Henoch syndrome, in Heptinstall RH (ed): Pathology of the Kidney. Boston, MA, Little, Brown, 1991, pp 389-476
26. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
27. Ong ACM, Fine LG: Loss of glomerular function and tubulointerstitial fibrosis: Cause or effect? Kidney Int 45:345-351, 1994
28. He J, Yang CW, Peten EP, Liu ZH, Patel A, Striker LJ, Striker GE: Collagen and collagenase mRNAs in normal and sclerotic glomeruli: Predictors of progression and response to therapy. Kidney Int 49:S39-43, 1995 (suppl)
29. Cameron JS: Proteinuria and progression in human glomerular diseases. Am J Nephrol 10:81-87, 1990 (suppl 1)
30. Solez K, Axelsen RA, Benediktssin H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Häyry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R, von Willebrand E, Yamaguchi Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44:411-422, 1993
31. Takemura T, Okada M, Akano N, Murakami K, Hino S, Yagi K, Takekoshi Y, Yoshioka K: Proto-oncogene expression in human glomerular diseases. J Pathol 178:343-351, 1996
32. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-488, 1991
33. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K: Expression of fas antigen and bcl-2 in human glomerulonephritis. Kidney Int 48:1886-1892, 1995
34. Makino H, Kashihara N, Sugiyama H, Sekikawa T, Ota Z: Role of apoptosis in the progression of glomerulosclerosis. Contrib Nephrol 118:41-47, 1996
35. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41:1134-1142, 1992
36. Abboud HE: Growth factors in glomerulonephritis. Kidney Int 43:252-267, 1993
37. Emancipator SN, Sedor JR: Cytokines in renal diseases, in Remick DG, Kunkel SL (eds): Cytokines in Health and Disease. Boston, MA, Marcel Dekker, 1992, pp 476-488
38. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964-972, 1987
39. Shikata K, Makino H, Morioka S, Kashitani T, Hirata K, Ota Z, Wada J, Kanwar YS: Distribution of extracellular matrix receptors in various forms of glomerulonephritis. Am J Kidney Dis 25:680-688, 1995
40. Rabb HA: Cell adhesion molecules and the kidney. Am J Kidney Dis 23:155-166, 1994
41. Kurihara H, Anderson JM, Farquhar MG: Increased Tyr phosphorylation of ZO-1 during modification of tight junctions between glomerular foot processes. Am J Physiol 268:F514-F524, 1995
42. Glassock R, Adler S, Cohen A: Primary glomerular disease, in Brenner EB (ed): The Kidney (ed 5). Philadelphia, PA, Saunders, 1996, pp 1419-1421
43. Lee GSL, Glassock R: Immunoglobulin A nephropathy, in Ponticelli C, Glassock R (eds): Treatment of Primary Glomerulonephritis. New York, NY, Oxford University Press, 1997, pp 186-217
44. Toshida Y, Mitarai T, Kawamura T, Kitajima T, Kanai T, Miyazaki Y, Kawaguchi Y, Kubo H, Nagasawa R, Ichikawa I, Sakai O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 86:2126-2169, 1995
45. Woo KT, Lau YK, Lee GSL, Wong KS, Wei SS, Chiang GSC, Lim C: Pattern of proteinuria in IgA nephropathy. Nephrology 3:31-34, 1997